Development and Validation of Predictive Models for Differentiating Resectable Stage III Peripheral SCLC from NSCLC Using Radiomic Features and Clinical Parameters
Objective Lung cancer is primarily categorized into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), each characterized by distinct therapeutic approaches and prognostic outcomes, particularly in stage III peripheral cases. This study aimed to develop predictive models utilizing...
Saved in:
| Main Authors: | Junjie Zhang MD, Ligang Hao MD, Qiuxu Zhang MD, Lina Zheng MD, Qian Xu PhD, Fengxiao Gao MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Technology in Cancer Research & Treatment |
| Online Access: | https://doi.org/10.1177/15330338251368956 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Turtle Study: A Phase 2 Study of Durvalumab Plus Carboplatin and Etoposide in Elderly Patients With Extensive-Stage SCLC (LOGiK 2003)
by: Hidenobu Ishii, MD, PhD, et al.
Published: (2025-07-01) -
What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer?
by: Sun Min Lim, MD, PhD, et al.
Published: (2025-09-01) -
CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC
by: Jay M. Lee, MD, et al.
Published: (2025-08-01) -
Temporal Trends in the Utilization and Survival Outcomes of Lobar, Segmental, and Wedge Resection for Early-Stage NSCLC, 2004 to 2020
by: Eden Z. Deng, BS, et al.
Published: (2025-03-01) -
Outcomes in Patients With Resectable Stage III NSCLC Who Did Not Have Definitive Surgery After Neoadjuvant Treatment—A Retrospective Analysis of the SAKK Trials 16/96, 16/00, 16/01, 16/08, and 16/14: A Brief Report
by: Sabine Raimann, MD, et al.
Published: (2025-06-01)